Two Sigma Investments’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88.9K | Sell |
10,059
-9,325
| -48% | -$82.4K | ﹤0.01% | 2961 |
|
|
2025
Q1 | $209K | Buy |
19,384
+9,159
| +90% | +$98.6K | ﹤0.01% | 2779 |
|
|
2024
Q4 | $131K | Sell |
10,225
-1,867
| -15% | -$23.9K | ﹤0.01% | 2871 |
|
|
2024
Q3 | $334K | Sell |
12,092
-7,817
| -39% | -$216K | ﹤0.01% | 2572 |
|
|
2024
Q2 | $577K | Sell |
19,909
-1,521
| -7% | -$44.1K | ﹤0.01% | 2232 |
|
|
2024
Q1 | $956K | Buy |
21,430
+9,356
| +77% | +$417K | ﹤0.01% | 1922 |
|
|
2023
Q4 | $468K | Buy |
12,074
+9,579
| +384% | +$372K | ﹤0.01% | 2418 |
|
|
2023
Q3 | $73.4K | Sell |
2,495
-295
| -11% | -$8.67K | ﹤0.01% | 2701 |
|
|
2023
Q2 | $177K | Sell |
2,790
-16,510
| -86% | -$1.05M | ﹤0.01% | 2587 |
|
|
2023
Q1 | $911K | Buy |
19,300
+11,084
| +135% | +$523K | ﹤0.01% | 1853 |
|
|
2022
Q4 | $570K | Buy |
+8,216
| New | +$570K | ﹤0.01% | 1907 |
|
|
2022
Q1 | – | Sell |
-3,638
| Closed | -$563K | – | 2878 |
|
|
2021
Q4 | $563K | Buy |
+3,638
| New | +$563K | ﹤0.01% | 1929 |
|